The Scientist

» clinical trials and disease/medicine

Most Recent

image: Infographic: Repurposing Strategies

Infographic: Repurposing Strategies

By | January 1, 2017

Novel uses for existing and failed drugs may save companies time and money in bringing new therapeutics to market.

0 Comments

Oncologists have raised concerns about a mouse study that suggests the vaccine for human papillomavirus could cause brain damage.

0 Comments

New approaches to treating cancer have shown great promise, but they also come with serious risks that give us cause for concern.

1 Comment

image: FDA OKs Clinical Trials of Ecstasy for PTSD

FDA OKs Clinical Trials of Ecstasy for PTSD

By | December 1, 2016

The illicit drug has shown promise in helping people with debilitating post-traumatic stress disorder.

0 Comments

image: Oligonucleotide Therapeutics Near Approval

Oligonucleotide Therapeutics Near Approval

By | December 1, 2016

Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.

0 Comments

image: Opinion: Not All Genetic Databases Are Equal

Opinion: Not All Genetic Databases Are Equal

By | December 1, 2016

Sorting out which data sets are clinical-grade is key to helping patients.

0 Comments

image: More Success Fixing Sickle Cell Gene with CRISPR

More Success Fixing Sickle Cell Gene with CRISPR

By | November 9, 2016

Researchers say they have sufficient in vitro and animal data to apply for human testing.

0 Comments

image: New Support for Experimental Alzheimer’s Drug

New Support for Experimental Alzheimer’s Drug

By | November 2, 2016

Merck’s verubecestat, which is currently being tested in two Phase 3 studies, is safe, according to newly published Phase 1 data.

2 Comments

Family members with a certain gene variant had unnecessary interventions, highlighting the potential hazards of precision medicine.

2 Comments

An early-stage study of the effectiveness of a lung-cancer vaccine developed by scientists in Cuba could start as early as next month.

0 Comments

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Humans Never Stopped Evolving
    Features Humans Never Stopped Evolving

    The emergence of blood abnormalities, an adult ability to digest milk, and changes in our physical appearance point to the continued evolution of the human race.

  4. Abundant Sequence Errors in Public Databases
Business Birmingham